54results about How to "Improve the success rate of treatment" patented technology

The present invention relates generally to methods of preventing or treating toxicities of the skin, hair, and/or nails, which are associated with administration of one or more epidermal growth factor receptor inhibitors, with light-emitting diode photomodulation treatment, either alone or in combination with other agents.

The invention discloses an identification method, and identification device and a storage medium for cancer. The identification method for cancer includes receiving a pathologic picture in the preparation of cancer identification, confirming the model of preset type corresponding to the pathologic picture in accordance with the mapping relation between the cancer type in the preparation of identification and the model of preset type; undertaking the identification process on the pathologic picture on the basis of the confirmed model of preset type and producing the result of identification. Byidentifying the picture segment in the cancerous region of the pathologic picture and judging whether the patients with the pathologic picture is afflicted with cancer, the identification method forcancer can improves the efficiency of identifying cancer.

The invention relates to the technical field of medical apparatuses, and in particular to a vascular radio-frequency ablation electrode catheter provided with claw-shaped catheter branches; a radio-frequency ablation working section is arranged on the front section of the vascular radio-frequency ablation electrode catheter , a catheter body section is arranged on the middle section of the vascular radio-frequency ablation electrode catheter and a control handle section is arranged on the rear section of the vascular radio-frequency ablation electrode catheter; the eight radio-frequency catheter branches extend from a peripheral direction of the radio-frequency ablation working section; the eight radio-frequency catheter branches are integrally represented as claw-shaped structures; and at least one ablation electrode is connected to the head end of each radio-frequency catheter branch. The vascular radio-frequency ablation electrode catheter provided by the invention has the beneficial effects that in practical clinical treatment, the vascular radio-frequency ablation electrode catheter provided with the claw-shaped catheter branches provided by the invention can be applied to various blood vessels differing in diameter and can be used for conducting radio-frequency ablation therapy on cardiac muscle tissues in a complex part, such as for vascular ablation of such diseases as paroxysmal atrial tachycardia, supraventricular tachycardia, atrial flutter, atrial fibrillation, resistant hypertension and the like.

An air channel controlling system of three-way vacuum valve for the ballistic lithotriptor is composed of a handset module, three-way vacuum valve module consisting of the valve body with 4 air channels and the valve core with 3 air channels, the connecting flexible tube and high-pressure air pump. It has high successful rate and safety.

The present invention relates generally to methods of preventing or treating toxicities of the skin, hair, and/or nails, which are associated with administration of one or more multikinase inhibitors, with light-emitting diode photomodulation treatment, either alone or in combination with other agents.

The invention provides a sacral nerve puncture guide plate and a construction method thereof. The guide plate comprises a base plate, an outer guide pipe and an inner guide pipe, wherein the outer guide pipe is arranged on the outer side face of the base plate; the inner guide pipe is coaxially arranged in the outer guide pipe; the inner guide pipe penetrates through the base plate; and the end face of the end, penetrating through the base plate, of the inner guide pipe is flush with the inner side face of the base plate. According to the sacral nerve puncture guide plate provided by the invention, the end face of the end, penetrating through the base plate, of the inner guide pipe is flush with the inner side face of the base plate, so that the tail end face of the inner guide pipe directly abuts against the skin in use and can be attached to the surface of the skin, whole-course guided puncture is achieved, and puncture errors are avoided.

The present invention relates generally to methods of preventing or treating toxicities of the skin, hair, and/or nails, which are associated with administration of one or more vascular endothelial growth factor receptor inhibitors, with light-emitting diode photomodulation treatment, either alone or in combination with other agents.

An emergency treatment quality evaluation management system comprises a patient registration system, an emergency treatment system, a data acquisition system, a data processing system and a managementevaluation system. The patient registration system is used for collecting basic identity information of a patient; the emergency treatment system is used for recording treatment first-aid informationof the patient, wherein the treatment first-aid information comprises disease information, treatment duration information and treatment result information of the patient; the data processing system comprises a data classification module, a data proofreading module, a data analysis module and a data evaluation summary sheet; and the management evaluation system comprises a data query module, a statistics module, a case classification module and a key case storage module. According to the system, not only can the treatment process of the disease be analyzed and evaluated, but also treatment failure cases can be analyzed, and thus the overall treatment success rate is improved.

The present invention provides a compound drug for treating diabetes, the compound drug is prepared by berberine intestinal controlled-release microcapsules and a common western medicine for treating diabetes, 10 to 90 percent of the daily maximum dose of the berberine which is the active ingredient in the berberine intestinal controlled-release microcapsules and 90 to 10 percent of the daily maximum dose of the active ingredient of one common western medicine which is chosen randomly for treating diabetes are used for compound preparation. The berberine intestinal controlled-release microcapsules used in the compound drug of the present invention are the effective drug for treating diabetes, and the microcapsule diameter is 35 to 5000 Mum. The present invention provides the compound drug for treating diabetes, which mainly makes use of the complementary synergistic effect of the main drugs to achieve the purpose of reducing the blood glucose. The compound drug of the present invention for treating diabetes has high treatment success rate, less toxicity, fewer side effects and lower dose; furthermore, the present invention can effectively improve the compliance of the medication of the patients, so as to enhance the effect of reducing blood glucose of the drugs treating diabetes.

The invention discloses a hickory nut root disease control method, and belongs to the technical field of seedling disease and pest control. The method comprises the following steps: dividing root diseases of hickory nut trees into three levels according to the degrees of disease severity; carrying out soil loosening; carrying out pouring or filling holes with a fertilizer-pesticide mixed solution; and solarizing the soil. The method has the advantages of practicability and wide active range, and often shows consistent performance in agriculture compared with a biological treatment method.

The present invention belongs-the technical field of biomedicines and provides a mycobacterium tuberculosis mutant gene and an application thereof. The mutant gene is a mutant gene in which an Rv1527cgene fragment is deleted in a H37Rv gene of a standard strain of mycobacterium tuberculosis, or a mutant gene with an alanine at 1380th position on the Rv1527c gene fragment of the mycobacterium tuberculosis is mutated to proline or glycine at 1637th position is mutated to alanine. The mutant gene is used as a biomarker of the mycobacterium tuberculosis for detection of clinical specimens of tuberculosis patients before treatment and conducive-clinical formulation of reasonable chemotherapy regimens, and thus improves a clinical successful treatment rate of tuberculosis patients, especially multidrug-resistant tuberculosis patients.

The invention provides a dental material. The dental material comprises a resin root canal sealant and DMADDDM, and also comprises magnetic nanoparticles (MNPs). The material can improve the dentin tubule permeability and antibacterial properties of the root canal sealant while maintaining the material properties of the sealant, so that the purpose of preparing a novel resin-type root canal sealant material with effective antibacterial properties and dentin permeability is achieved.